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We attempted to determine the level of sweat kallikrein 
(kininogenase) and to purify and characterize it using sweat 
collected over a white petrolatum barrier. Thermally induced 
eccrine sweat obtained from 24 healthy subjects showed kal-
likrein activity of 24.4 ng kinins generated/1 mg of sweat 
protein when heated plasma was used as the substrate and 
16.1 ng kinin when purified low molecular weight bovine 
kininogen was used as the substrate. Sweat was sequentially 
purified by Sephacryl S-200, diethyaminoethyl Sephacel, 
and fast flow liquid chromatography Mono Q chromatogra-
phy. Sweat kallikrein had aMrof 40,000 and was inhibited by 
aprotinin but not by soybean trypsin inhibitor. The peptide 
generated by sweat kallikrein was identified as lys-bradykinin 
using reverse phase high-performance liquid chromatogra-
phy and by its amino acid sequence. Anti-human urinary 
kallikrein immunoglobulin G neutralized the sweat kal-
likrein activity completely, indicating that the sweat 
T he eccrine sweat gland shares a number of features with other exocrine glands, especially with regard to the mechanisms involved in the secretion of fluids, electrolytes, and nonelectrolytes [1 ,2]. Both the sali-vary gland and saliva contain high concentrations of 
glandular kallikrein, a serine protease [3]. Kallikreins (or kinino-
genases) are also present in a variety of other tissues and body fluids 
[4-8]. It has been postulated that glandular kallikrein serves many 
functions including the regulation of salivary glandular blood flow 
through kinin generation [9], proteolytic processing of various 
growth factors and polypeptide hormones [10], and the regulation 
of membrane transport also via kinin generation [11-13]. 
Thermoregulatory eccrine sweating is associated with active re-
flex vasodilation (ARV) [14]. In patients with hereditary anhidrotic 
ectodermal dysplasia where sweat glands are congenitally absent, 
AR V does not occur during heat exposure despite the fact that their 
sympathetic innervation to cutaneous blood vessels appears to be 
normal [15]. Whether or not the ARV during heat-induced sweat-
ing is due to bradykinin produced by the sweat gland and the lack of 
ARV in anhidrotic ectodermal patients is due to the absence oflocal 
bradykinin production are unknown. Nevertheless, evidence for 
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kallikrein is the glandular type. Purified sweat and salivary 
kallikrein showed similar Mr and responses to inhibitors and 
antibodies. Using immunohistochemistry, kallikrein activity 
was localized in luminal ductal cells and in the peripheral rirn 
of secretory coil segments, presumably the outer membrane 
of the myoepithelium. We also observed kininase activity in 
sweat at Mr 160,000, which was inhibited by ethylenedia-
mine tetraacetic acid, captopril, and angiotensin converting 
enzyme inhibitor peptide, indicating that it is kininase II (or 
angiotensin converting enzyme). Sweat also contains abun-
dant non-kallikrein hydrolases for S-2266 and S-2302. The 
demonstration of glandular kallikrein, its tissue localization, 
and the presence of kininase II in sweat provide the basis for 
future studies on the physiologic role of the kallikrein/kinin 
system in the eccrine sweat gland. Key words: ki,tinoge1lase/ 
sweat gland/protease. ] Invest Dermatol1 02:214 - 220, 1994 
the presence of a kallikrein/kinin system in the eccrine sweat gland 
is hard to dismiss. Fox and Hilton [16] first reported in 1958 that 
eccrine sweat and peri glandular dermal fluid contained a substance 
that contracted the rat uterus when such fluids were preincubated 
with pseudo-globulin. They interpreted the finding as indicating 
that bradykinin was produced from pseudo-globulin by kallikrein in 
sweat or dermal fluid. Frewin et al [17] also observed weak kinin-
generating activity in sweat samples from some, but not all, subjects 
during exercise. Fraki et al [18] showed benzoyl-L-arginine ethyl 
ester (BAEE) - hydrolyzing, aprotinin-sensitive proteinase in 
human sauna sweat, which suggests that sweat may contain kal-
likrein-like enzymes. During the course of the present study, May-
field et al [19] also observed that human sweat contains immunore_ 
active glandular kallikrein with kinin-generating activity by using 
radioimmunoassays for kallikrein and for generated kinin. Never-
theless, the kallikrein activity was absent or near the detection limit 
of the ~ssay ~ystem. in some unconcentrated sweat samples. Further-
more, 111 their studies, sweat samples were not collected over a White 
petrolatum barrier and the sodium concentration in some of their 
sweat samples was abnormally high [19]. Thus the possibility of 
epidermal contamination and evaporative water loss in some of their 
sweat samples cannot be entirely ruled out. 
The goals of the present study have been 1) to confirm the pres-
ence of kallikrein activity in clean sweat, 2) to determine whether 
hydrolysis of synthetic substrates reflects the kallikrein activity in 
sweat, 3) to determine that sweat kallikrein is of the glandular (or 
tissue) type, but not the plasma type, 4) to study whether or not 
kinin-degrading enzyme(s) (i.e., kininase II) is also present in sweat, 
and 5) to study the localization of kallikrein in the sweat gland using 
immunohistochemistry . 
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Figure 1. Kininogenase and kininase activity in thermally induced sweat 
from the back. The solid line in A is the temperature protocol used through-
out the present sauna experiments. The mean sweat rate was derived from 
[20]. B) Time course of kallikrein (solid symbols) and kininase (open symbols) 
activity in sweat, expressed as ng kinin production from LMW kininogen or 
ng bradykinin degradation per ml of sweat/h, respectively. C) Kinin pro-
duction versus total sweat output (m1j50 min/m2 on the back) in 24 men, 
ages 18-30. tI, number of subjects. Open circles, kinin production from HP 
and solid triallgles from bovine LMW kininogen. Kinin production was ex-
pressed on a per-sweat protein basis (which is similar to that expressed on the 
sweat volume basis because sweat protein content is similar in different sweat 
samples; not shown). Approximately 24.4 ± 15.4 ng of kinin was generated 
by 1 mg of sweat protein for the HP (used as substrate) and 16.1 ± 13.6 ng 
for bovine LMW kininogen (used as substrate), which correspond to 0.18 ng 
and 0.16 ng of kinins generated by 1 ml of original sweat, respectively. 
When EDTA and 1,10 phenanthroline were not included in the assay mix-
ture for kinin, detection of kinin was dramatically decreased (data not 
shown), consistent with the observation that kininase is also present in 
human eccrine sweat (see B) . 
MATERIALS AND METHODS 
Materials Trizma base, phenylmethyl sulfonyl fluoride (PMSF), diiso-
propylfluorophosphatc (DFP), l,lO-phenanthroline, trypsin (type III), pa-
pain (type III), benzoyl-arginine-p-nitroanilide (BANA), aprotinin, soybean 
trypsin inhibitor (SBTI), bradykinin, Iys-bradykinin (kallidin), angiotensin 
converting enzyme (ACE) inhibitor (Gln-Trp-Pro-Arg-Pro-Gln-I1e-Pro-
Pro), and angiotensin I were obtained from Sigma Chemicals, St. Louis, 
MO. Ethylenediamine tetraacetic acid (EDTA) was purchased from MCB 
Manufacturing Chemicals, Cincinnati, OH. Sephacryl S-200, diethylamin-
oethyl (DEAE) Sepharose, cyanogenbrornide (CNBr)-activated Sepharose 
4B, Dextran T 70, and prepackaged Mono Q column (HR 5/5) were pur-
chased from Pharmacia (Uppsala, Sweden). VyDAC reverse-phase col-
umn C\8 was obtained from Bio-Rad, Hercules, CA. Val-Leu-Arg-pNA 
(S-2266), and Pro-Phe-Arg-pNA (S-2302) were purchased from Kabi, 
Stockholm, Sweden. The enzyme immunoassay kit for kinins was obtained 
from Dainippon Pharmaceuticals (Suita,Japan). Purified bovine low molec-
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Figure 2. Kininogenase activity as determined using natural subrates versus 
synthetic substrates. A) Comparison of kinin generation from bovine LMW 
kininogen and human HP. B) Comparison of kinin generation from HP and 
hydrolysis of S-2266 (widely used substrate for glandular kallikrein) and 
5-2302 (substrate for plasma kallikrein). C} Comparison of kinin generation 
from bovine LMW kininogen and hydrolysis ofS-2266 and S-2302. Sweat 
samples from each subject were pooled and concentrated. The correlation 
between the hydrolysis ofS-2266 and that ofS-2302 is R = 0.90, P < 0.001, 
Y = 0.95X -0.12, not shown. 
ular weight (LMW) kininogen was purchased from Seikagaku Kogyou, 
Tokyo, Japan. Purified bovine pancreatic kallikrein was a gift of Showa 
Denko Co. Ltd., Tokyo, Japan. StrAvigen was purchased from Biogenex 
Laboratories, San Ramon, CA. Rabbit antiserum to human urinary ka.Ilikrein 
was obtained from Japan Chemical Research, Kobe,Japan. Norit A was the 
product of Fisher Scientific, Fair Lawn, NJ. USP Vaseline was used as white 
petrolatum. All other reagents were purchased from Sigma. 
Sweat Collection To obtain thermally induced sweat samples with a 
minimum of epidermal contamination and evaporative water loss, sweat was 
collected inside a plastic film or bag over a white petrolatum barrier placed 
on the skin [20,21]. For the time-course study (Fig 1), sweat was collected 
from a rectangular area, 30 X 35 cm2 , on the upper back. The room temper-
ature was increased stepwise from 45 to 52.5 °C (see Fig 1, top) over the 
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Figure 3. Sephacryl S-200 gel chromatography of concentrated clean 
sweat. The column, 3.2 X 80 em, was eluted with phosphate-buffered sa-
line and 5.5-m1 fractions collected. A) Kinin generation from bovine LMW 
kininogen (opell triangles) and that from heated plasma (solid triallgles) . M,. for 
the peak is around 40,000. Kallikrein-rich fractions indicated with a bar were 
pooled and further purified. B) Hydrolysis of S-2266 (open circles) and 
S-2302 (solid circles) by the same fractions as in (A). Note that the peaks of 
hydrolytic activiry are around M, 50,000. C) Bradykinin-degrading activity 
(solid squares) and angiotensin I-degrading activity (open squares) in the same 
fractions as in (A) . 
50-min period while the relative humidity was kept at 70%. Sweat was 
collected continuously by suction from the reservoir of the bag, pooled every 
5 min, and placed on ice. Collected sweat was filtered through a Millipore 
HA membrane (0.22 mm) and concentrated about 10 times using an Amicon 
YM 10 membrane (the exact concentration factor was calculated for each 
sweat sample) at 4·C and stored at -70·C until use. Pooled sweat samples 
used for the chromatographic purification of kallikrein and kininase were 
collected in the same fashion but from the entire upper trunk and with the 
trunk and arms (painted with Vaseline) tightly occluded with a large plastic 
bag [21]. Pooled sweat samples were concentrated about 100 times by filtra-
tion with an Amicon YM 10. The absence of epidermal contamination was 
confirmed by the absence of aminopeptidase activity (which is derived al-
most exclusively from the epidermis) in sweat samples [21]. 
Enzyme-Linked Immunoassay for Kinins Human citrated plasma 
that contains both LMW and high molecular weight (HMW) kininogens 
was heated at60 · Cfor30 minin the presenceof4 mM 1,10-phenanthroline 
to inactivate plasma kininases. It was used as the substrate for determination 
of the total (i .e., plasma and glandular) kallikrein activity. Purified bovine 
LMW kininogen was used to determine glandular kallikrein activity. 
Twenty microliters of concentrated sweat and 20 III of buffer (100 mM 
Tris-HCI, pH 8.5, + 5 mM EDTA + 5 mM 1,10-phenanthroline) were 
incubated with 20 III of heated plasma (HP) or LMW bovine kininogen (0.5 
mg/ml) at 37· C for 60 min. The reaction was stopped by the addition of 
20 III of trichloroacetic acid (TCA). Generated kinins were determined ac-
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cording to the method of Ueno et al [23], using an assay kit (Markit A 
Bradykinin). 
Synthetic Substrate Assay Kallikrein-like activity was also measured 
using the synthetic peptide substrates S-2266 and S-2302. Fifty- to one 
hundred-microliter samples (sweat or eluates from columns) were incubated 
in test tubes containing 400 III of 50 mM Tris-HCl (pH 8.5) and 50,u1 of 
4 mM S-2266 or S-2302 at 37"C for 10-30 min. The reaction was termi-
nated by adding 50 III acetic acid. The absorbance at 405 nm was deter-
mined. Enzyme activity was expressed as nmol/min/ml of p-nitroaniline 
liberated, assuming E40S = 10,500 [24]. 
Kininase Assays Kininase activity was expressed as the rate of degradation 
of exogenous bradykinin by samples in the absence of EDT A or 1,10-phen_ 
anthroline. The reaction mixture consisted of 20 III of sample (typically 
containing around 0.1 ng of bradykinin), 40 III of anti pain mixture (20 
mg/ml of antipain in 0.4 M hydroxyethylpiperazine ethanesulfonic acid 
[HEPES], pH 8.0) + 0.4 M NaCI), and 20 III of bradykinin (400 ng/mI). 
After incubation at 37 · C for 30 min, the reaction was stopped by the addi_ 
tion of 20 III TCA. The residual kinin was measured by the enzyme-linked 
immunoassay. 
Angiotensin I Degradation The fifty-microliter sweat sample and 25-pl 
buffer (0.4 M HEPES + 0.4 M NaCl, pH 8.0) were incubated with 25,u1 of 
angiotensin 1(20 mg/ml) for 3 hat 37"C. After boiling the reaction mixture 
for 5 min, anti-angiotensin I serum (200 Ill) and !2SI-angiotensin I (50 pi, 
5000 cpm) were added and incubated for 24 h at 4· C . The antibody-bound 
angiotensin I was removed by adding 200 III of dextran-coated charcoal 
(1.25% Norit A and 0.25% Dextran T 70) and the radioactivity of free 
angiotensin I in the supernatant determined using a Beckman gamma 
counter. 
Purification of Sweat Kallikrein Concentrated pooled sweat samples 
(5-7.5 ml of 100X) obtained from 15 subjects were applied to a Sephacryl 
S-200 gel column equilibrated with 20 mM phosphate buffer (pH 7.2) con-
taining 0.14 M NaCI. The kallikrein-rich fractions were pooled (bar in Fig 
3) and applied to a DEAE-Sepharose column equilibrated with 20 ruM 
phosphate buffer (pH 7.0) . Elution was performed by a linear gradient of 
NaCI (see Fig 3). The pooled kallikrein-rich fractions (bar in Fig 4) were 
further purified by fast flow chromatography (FPLC) using an anion-ex_ 
change (Mono Q) column equilibrated with 20 mM Tris-HCl (pH 8.0). 
Purification of Salivary Kallikrein Salivary kallikrein was also puri-
fied from human mixed saliva by acetone precipitation followed by sequen_ 
tial column chromatography as described above. The final kallikrein frac-
T 
E 
c 
c 
00 
N 
0; 
fl 
c 
.. 
-e 
o 
f/) 
.c 
'" 
.6 A 
.4 
.2 
I ,. 
B 
• S-2266 
o S-2302 
-
o II .,I;); r r=I/--',..,..-,-,..-';P¥~~ 
10 20 30 70 80 90 100 
Fraction number 
16~ 
j 
:s 
12~ 
.6 
-oS , , 
8~ 
, 
, 
...... 
l!! ~ 
11 .2 .E 
4~ t::' U 
'c .. 
S2 ~ 
0 0 
Figure 4. DEAE-Sepharose chromatography of the kallikrein-rich fraction 
from Fig 3. A) Kinin liberation from LMW kininogen. B) Synthetic sub-
strate hydrolysis. Note that the majority of S-2266 and S-2302 hydrolytic 
activities were separated from the peak kallikrein activity. Fraction volume 
was 2.8 mi. 
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Figure 5. FPLC Mono Q chromatography of the peak fraction from Fig 4. 
Note that the S-2266 hydrolytic activity (B) now eluted with the peak 
kallikrein activity (A). Fraction volume was 1 ml. S-2302 hydrolase activity 
was undetectable (not shown). The specific activity of kallikrein increased 
300 times, with a yield of 9%. 
tions showed two protein bands at M, 38,000 and 41,000 on the sodium 
dodecyl sul fate (SOS) polyacrylamide gel. Both bands reacted with anti-ur-
inary kallikrein IgG on immunoblotting. When enzyme-linked immunoas-
say for kinins was performed, 1 ng of purified salivary kallikrein liberated 
36 ng of kinins/h. This preparation was also used as a positive control and a 
standard in the sweat kallikrein assays. 
Purification of Human HMW Kininogen Human HMW kininogen 
was partially purified as previously described [25] . The amount of kininogen 
was measured by papain inhibition using benzoyl-arginine-naphthylamide 
(BANA) as a substrate [25]. The final preparation liberated 0.5 mg of kinin/ 
mg protein/h when incubated with an excess amount of human urinary 
kallikrein. 
Determination of Kinin Species Fifty microliters of the sweat kal-
likrein fraction from the Mono Q chromatography was mixed with 25 III of 
human HMW kininogen and incubated for 60 min at 37 °C. After the 
addition of 25 ml TCA, the supernatant was lyophilized and redissolved in 
20 ml of 10% acetonitrile containing 0.1% trilluoroacetic acid. Samples 
were isolated by reverse-phase high-performance liquid chromatography 
(HPLC) using a VyOAC CIS column. The sequence of the isolated peptide 
was determined using an Applied Biosystem 470 A Protein Sequencer. 
Effect of Aprotinin, Soybean Trypsin Inhibitor, and Anti-Human 
Urinary Kallikrein IgG on Sweat Kallikrein Twenty microliters of 
the sweat kallikrein fraction (from the Mono Q chromatography) was mixed 
with various concentrations of inhibitors (20 Ill), or phosphate-buffered 
saline (PBS) mixed with 20 III of assay buffer (as control) and incubated for 
30 min at 25 ° C. After the addition of 20 III of heated plasma, the reaction 
mixture was incubated for 60 min at 37" C and the generated kinins deter-
mined by enzyme immunoassay. Salivary and pancreatic kallikrein prepara-
tions were diluted to yield a kininogenase activity comparable to that of the 
sweat Mono Q fraction in Fig 5. 
Purification of Sweat Kininase After Sephacryl S-200 gel chromato-
graphy of the concentrated sweat, the kini11ase-rich fractions were further 
purified by Mono Q and Superose 12 chromatography. 
In1munohistochemical Localization of Sweat Kallikrein Anti-hu-
man urinary kall ikrein IgG was purified with a protein A-Sepharose column 
followed by an aprotinin-Sepharose column to remove contaminating plas-
min. Five-rnicrometer-thick cryostat sections of human skin were stained 
with anti-urinary kallikrein IgG diluted variously from 1: 100 to 1: 500, 
then with streptavidin. Appropriate controls were used. 
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RESULTS 
Because the kallikrein (or lcininogenase) levels in some unconcen-
trated sweat samples were near or below the detection limit of the 
assay system [17,19]' we chose to concentrate all of our sweat sam-
ples by ultrafiltration. The loss of enzyme activity during ultrafil-
tration may be minimal, if any, and to similar degrees in different 
samples. In fact, kallikrein was not recovered from the freshly used 
YM 10 membranes by exhaustive elusion (unpublished) and the 
mean kallikrein activity (Fig IB) was rather comparable to those 
reported by Mayfield et af [19], who used unconcentrated sweat 
samples. Figure 1B (solid symbols) shows that the mean kallikrein 
activity remained constant with time of sweating, suggesting that 
kallikre.in was not an epidermal contaminant (because epidermal 
contammants tend to show higher concentrations in the first few 
sweat samples than in later samples) [20] but was secreted by the 
sweat gl~nd on a continuous basis. Also shown in Fig 1B (open 
:ymbols) IS ~hat s:veat also contains kininase (kinin-degrading) activ-
Ity. As depicted m Fig 1 C, when kallikrein activities were compared 
with total sweat volumes (collected from the upper trunk over a 
50-min period as an indirect measure of one's maximal sweat rate), 
the correlation was absent, indicating that the kallikrein level in 
sweat is not determined by the factors that influence the sweating 
rate, e.g., degree of fitness or acclimatization. 
We then addressed whether or not the synthetic substrates 
S-2266 and S-2302, widely used for the determination of glandular 
and plasma kallikrein activities [26-28], respectively, are feasible 
for the determination of kallikrein activity in sweat. If hydrolysis of 
these synthetic substrates by sweat enzymes reflects kallikrein activ-
ities in sweat, then the superior sensitivity and simplicity of these 
substrates would make them extremely useful for further physio-
logic studies of sweat kallikrein. Thus we determined kinin genera-
tion from both HP (which contains both HMW and LMW kinino-
gens; glandular kallikrein hydrolyzes both kininogens but plasma 
kallikrein works only on HMW kininogen) and bovine LMW kin-
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was measured by enzyme immunoassay for kinins and the result expressed 
the percent inhibition. 
218 HIBINO ET AL 
A B 
inogen (substrate for glandular kallikrein) to examine whether 
there was a quantitative correlation between kinin generation and 
the hydrolysis of the synthetic substrates. As expected, the correla-
tion between kinin production from bovine LMW kininogen and 
from human HP was significant (Fig 2A), although HP produced 
more kinins than did LMW kininogen. This suggests that either 
bovine LMW kininogen is a poor substrate for human glandular 
kallikrein [29] or that sweat contains both types of kallikrein and 
thus produced more kinins from the HP (which will also be ad-
dressed later). As shown in Figs 2B,C, the correlation between hy-
drolysis of the synthetic substrates and kinin liberation from both 
natural substrates was absent, suggesting that sweat enzymes in-
volved in hydrolysis of these synthetic substrates may be different 
from kallikrein. Such a problem is readily resolved because the 
elution profile from the Sephacryl S-200 gel chromatography of 
concentrated sweat showed only one peak of kallikrein activity at 
around Mr 40,000 regardless of whether HP or LMW kininogen 
was used as the substrate (Fig 3A). This indicates that a single en-
zyme, most likely glandular kallikrein, is involved in the generation 
of kinin from both LMW and HMW kininogens (i.e., human 
plasma kallikrein has a Mr of 90,000 [24] and the chromatography 
should have shown two peaks at MrS 40,000 and 90,000 when HP 
was used). The hydrolytic activities of both S-2266 and S-2302 
were eluted slightly to the left of the kallikrein peak, with the peak 
activity at around Mr 50,000 (Fig 3B), but because of the wide 
overlap with kallikrein activity, no definitive conclusion can be 
drawn from these data alone. Also shown in Fig 3C is the kininase 
(bradykinin-degrading) activity and angiotensin I - degrading ac-
tivity, both of which eluted in the same fractions at approximately 
Mr 160,000 (Fig 3C). This is of interest because ACE (which hy-
drolyzes angiotensin I to generate angiotensin II) is identical with 
kininase II, a dipeptidyl carboxypeptidase [30,31]. When the kal-
likrein-rich fraction in Fig 3 was further purified by DEAE-Sephar-
ose chromatography, the kallikrein activity was eluted at about 
0.35 M NaCI concentration (Fig 4A), whereas major S-2266 and 
S-2302 hydrolytic activities were eluted at 0.1-0.2 M NaCl, indi-
cating that sweat contains abundant non-kallikrein proteases that 
hydrolyze these synthetic substrates. Further purification of the 
kallikrein-rich fraction from DEAE-Sepharose chromatography 
(bar in Fig 4A) with a Mono Q column removed most of the non-
kallikrein S-substrate hydrolases so that the small peak of S-2266 
hydrolase now co-eluted with the kallikrein activity (Fig 5). The 
sensitivity of the Mono Q-purified kallikrein fraction to aprotinin 
and soybean trypsin inhibitor (SBTI) is shown in Fig 6. As shown, 
sweat kallikrein, as well as bovine pancreatic and human salivary 
kallikrein, was inhibited by aprotinin, but not by SBTI, in a dose-
dependent fashion. Because tissue kallikrein is sensitive to apro-
tinin, but not to SBTI, and plasma kallikrein is sensitive to both 
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Figure 7. Immwlohistochem_ 
ical localization of sweat kal-
likrein. Skin sections were 
treated with anti-urinary (iden-
tical with glandular) kal-
likrein IgG. The luminal 
ductal cells, especially near 
the cuticular border, are pos-
itive for kallikrein (arrow in 
A). Secretory coils are shown 
in (B), where the peripheral 
cells, presumably myoepith-
elial cells, are most densely 
stained (arrow in B). Sections 
treated with the antibody 
pre incubated with excess sal-
ivary kallikrein showed no 
staining (not shown). Scale 
bar, 100 11m. 
inhibitors, sweat kallikrein is most likely of the glandular type. In 
fact, the antibody inhibited salivary kallikrein activity by 97%, kal-
likrein activity of the concentrated sweat by 96%, and Mono Q_ 
purified sweat kallikrein by 99% (not illustrated), further suppon-
ing the idea that sweat kallikrein is of the glandular type (because 
urinary kallikrein is identical with glandular kallikrein [32]). One 
final bit of evidence to establish the identity of sweat kallikrein as 
the glandular type would be to confirm that the kinin produced by 
sweat kallikrein is Iys-bradykinin (or kallidin) rather than brady_ 
kinin. In fact, when the sweat kallikrein fraction was incubated with 
human HMW kininogen and the supernatant run on a HPLC 
VyDAC C1S column (B), a sharp peak corresponding to Iys-brady_ 
kinin was observed (data not illustrated). Furthermore, sequence 
analysis of the kinin liberated by sweat kallikrein was that of 
Iys-bradykinin, i.e., Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg. 
Having identified sweat kallikrein as the glandular type, we then 
localized kallikrein in the sweat gland using immunohistochemis-
try. The kallikrein activity was localized in the luminal membrane 
of the duct cells (arrow in Fig 7 A) and the peripheral rim of the 
secretory coil segment (arrow in Fig 7B), presumably along the 
peripheral membranes of the myoepithelial cells. 
Finally, a limited attempt was made to characterize the sweat 
kininase already shown in Figs 1 and 3. The kininase-rich fraction 
obtained from the Sephacryl S-200 gel chromatography (see Fig 
3C) was applied to a Mono Q column. As shown in Fig 8, kininase 
and angiotensin I-degrading activity were separated into two peaks, 
F-I and F-II. Both F-I and F-II were further purified by Superose 12 
gel chromatography. Both F-I and F-U eluted at Mr 160,000 (not 
shown). In fact, as listed in Table I, F-I and F-II showed comparable 
responses to various proteinase inhibitors. EDT A and 1, lO-phen-
anthroline completely abolished the kinin-degrading activities of 
both fractions, indicating that sweat kininase is a metalloproteinase. 
Inhibition of sweat kininase by the inhibitors of ACE, captopril (SQ 
14,225), and Gln-Trp-Pro-Arg-Pro-Gln-Ile-Pro-Pro, further sup-
ported the thesis that the enzyme is kininase II (which is identical 
with ACE) [30,31]. 
DISCUSSION 
Kallikrein-like enzymes have been reported to occur in human ec-
crine sweat [16-19,33]; however, no ultimate proof has been 
presented to date. Thus the initial goal of the present study was to 
confirm the presence of kallikrein in sweat. In the course of the 
study, we have also observed that the sweat gland secretes kal-
likrein-like enzymes on a continuous basis, that sweat kallikrein is 
of the glandular type, and that immunoreactive kallikrein can be 
localized in luminal ductal cells and in the peripheral rim of the 
eccrine secretory coil, presumably in the outer membrane and/or 
cytoplasm of the myoepithelial cells. Furthermore, we have also 
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Figure 8. FPLC anion-exchange chromatography of sweat kininase. The 
kininase-rich fractions obtained from Sephacryl S-200 gel chromatography 
(Fig 3) were applied to a Mono Q column. Kinin-degrading activity was 
separated into two fractions (F-I and F-I1, bars) . Both kinin and angiotensin 
degradation are expressed as ng degradation/him!. 
observed that sweat contains abundant S-substrate hydrolases of 
non-kallikrein origin and kininase II, which is the same as ACE. We 
confirmed that sweat does not contain plasma kallikrein, a HMW, 
complex protease involved in intrinsic blood coagulation [8]. Al-
though the present study does not address the possible function of 
the kallikrein/kinin system, the occurrence of both kinin-generat-
ing (kallikrein) and kinin-eliminating (kininase II) enzymes sug-
gests its functional roles in the regulation of glandular function. For 
example, the presence of kallikrein in the luminal ductal cell of the 
sweat duct suggests its role in ductal function. Likewise, the pres-
ence of kallikrein in the basolateral rim of the secretory coil suggests 
that kallikrein can act on plasma LMW kininogen to produced 
lys-bradykinin, which could be instrumental in increasing periglan-
dular blood flow. If this thesis is proved to be the case, it can readily 
explain why patients with anhidrotic ectodermal dysplasia lack 
ARV [14] during heat exposure. The consequence of this lack 
would make these patients extremely susceptible to hyperthermia 
because heat transfer from the body core to the skin surface is also 
compromised due to the lack of ARV, minimizing the effectiveness 
of evaporative cooling when they wet the skin with water. 
Table I. Effect of Proteinase Inhibitors on Kininase Activity in 
Fractions F-I and F-II" 
None 
DFpb (1 mM) 
PMSF' (1 mM) 
Iodoacetamide (1 mM) 
EDTA (1 mM) 
1, 10 phenanthroline (1 mM) 
Pepstatin (10 mg/ml) 
ACE Inhibitord (10 mg/ml) 
Captopril (1 mg/ml) 
F-I 
o 
o 
o 
o 
100 
92 
10 
96 
98 
Inhibition (%) 
F-I1 
o 
o 
o 
o 
100 
98 
5 
90 
100 
• The inhibitors were added to the reaction mixture (see Materials and Methods) and 
incubated for 30 min at 37°C. The reaction was stopped by the addition of 20 pI 
trichloroacetic acid and the residual kinin determined by enzyme-linked immunoassay. 
The result is the mean of a triplicate assay. 
; Diisopropyl f1uorophosphate. 
, Phenylmethylsulfonyl fluoride. 
J Gln-Trp-Pro-Arg-Pro.Gln-ile-Pro.Pro. 
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Tissue (or glandular) kallikrein is actually a generic term for a 
family of serine proteases of closely related structure that are found 
in many mammalian tissues [34,35]. In the rat and mouse, at least 
five major gene products are intensely studied, i.e., the y subunit of 
7S nerve growth factor (N GF),,ON GF, which forms a complex with 
~ and yN~F,,ONGF-endopeptidase, epidermal growth factor-bind-
~ng protem, and glandular kallikrein [10,34]. It remains to be stud-
Ied whether human sweat and salivary kallikrein belong to a similar 
subgroup of a gene family. 
. ~ysyl-bradykinin (kallidin, an octapeptide cleaved from LMW 
kmmogen by gla~dular kallikrein) ~nd bradykinin (nonapeptide) 
are strong vasodtlators. These kinms also stimulate membrane 
tr.ansport [~1- ~3]. In the present immunohistochemical study (see 
Fig 7), kallI~em was localized in the luminal ductal cell especially 
ne~r the cut1c~lar border, which is a ring of dense tonofilaments 
~nslde the lummal membrane, suggesting that the enzyme is located 
mtracellularly near the ductal lumen. This is analogous to the kid-
ney collectmg tubule and the salivary duct [3,36], where kallikrein 
is produced in the cell interior and secreted into urine or saliva 
respe.ctive!y. It ren:ains unknown where kallikrein plays a majo; 
physlOlog~c role, either intracellularly or in the ductal lumen (in 
sweat). If l~tracellular kallikrein is the enzyme that is involved in 
the regulatIOn of cellular function, then its substrate LMW kinino-
gen.or i~s equivalent, m~st be present in the sweat giand cell. If not, 
kallIkrem mu~t be play~ng a role different from kinin generation, 
e.g., proteolyt~c p:o~essmg of other peptide hormones and growth 
factors. If k~l~lkrem m sweat plays a major functional role, then its 
substrate (kmmogen) must be in the luminal membrane of the duct 
and be readily accessible to sweat kallikrein because we failed to 
detect kininogen-like activity in human sweat collected from the 
skin surface (unpublished; Poblete et ai, however, were able to local-
ize kininogen in the dark cells [37]). In cultured sweat ductal cells 
bradykinin !s ~own to stimulate sodium transport [38]. The baso~ 
!aterallocallzatlon of the kallikrein-like immunoreactivity is also of 
~nterest be~ause the e~yme. may be accessible to LMW kininogen 
l~ t.he pe~lglandular. mterstItlum for the generation of lys-brady-
kuun, w~lch may ~e mstrumental in enhancing peri glandular blood 
flow dUrIng sweatmg. The presence of kininase II (ACE), an en-
zyme that degrades bradykinin and Iys-bradykinin (or the same 
enzyme that con."~r~s angiotensin I to angiotensin II), indirectly 
supvorts t.he POSSibilIty that the kallikrein/kinin system (or renin/ 
anglOtensm s'ystem) may be functionally involved and that kinin 
may be fun~t~onal only locally near the site of production. Locally 
produced bnms would be immediately inactivated by the abundant 
kininase II in sweat. 
. In. summary, we have. confirmed the presence of glandular kal-
!tkrem and klIlmase II 111 human sauna sweat and observed that 
immunoreactive kallikrein is localized in the luminal cell and in the 
basol~teral site. of ~he ~ecretory coil, raising the possibility that a 
functIonal kallIkrem/km1l1 system exists in the sweat gland. Thus 
the 'present study pr?vid.es the basis for future studies on the physio-
logiC role of the kallikre1l1/kinin system in the sweat gland in heal th 
and disease. 
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